[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(10/22, THU) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)

 머크가 "사는" 항암제 임상 데이터 '5가지 조건' 
[https://www.biospectator.com/news/view/30121](https://www.biospectator.com/news/view/30121)

 나노24, '엑소좀+CD24' 호흡곤란 2b상 "호흡부전 감소"
[https://www.biospectator.com/news/view/30136](https://www.biospectator.com/news/view/30136)

 길리어드, '경구 α4β7 저해제' UC 2상 "반응률 66% 
[https://www.biospectator.com/news/view/30138](https://www.biospectator.com/news/view/30138)

 씨어스, 용인 신공장 개소..웨어러블패치 캐파 "1.6배↑"
[https://www.biospectator.com/news/view/30156](https://www.biospectator.com/news/view/30156)

 릴리 임상팀서 제시하는 "비만 임상개발, 韓의 전략은?"
[https://www.biospectator.com/news/view/30105](https://www.biospectator.com/news/view/30105)

 셀트리온, 美카이진서 'APRIL 항체' 5.8억弗 사들여
[https://www.biospectator.com/news/view/30157](https://www.biospectator.com/news/view/30157)

 셀트리온, 분기 영업이익 5000억 돌파 "동력은?"
[https://www.biospectator.com/news/view/30142](https://www.biospectator.com/news/view/30142)

 애스톤, 대만 한코와 '면역항암제 병용요법' MOU
[https://www.biospectator.com/news/view/30159](https://www.biospectator.com/news/view/30159)

[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(10/22, THU) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)